Milan/Graz – 22 September 2026 – Medisolve, the European leader in maintenance and integrated services for biomedical equipment, today announces the acquisition of Mides Healthcare Technology GmbH, a European platform specialising in the repair, maintenance and refurbishment of medical equipment, from Allistro, a European private equity fund. Mides, headquartered in Graz, Austria operates in the most of European countries with a focus in Germany, Austria and Switzerland.
Mides will strengthen Medisolve’s laboratory platform and will become the Group’s European innovation hub focusing on complex repair. Mides, leveraging the strong relationships it has developed with its customers, will leverage MediSolve platform expanding the range of services offered.
The transaction confirms Medisolve’s strategy, based on a combination of organic growth and selective acquisitions, aimed at supporting the consolidation of the European biomedical equipment services market, which remains highly fragmented
With this acquisition, Medisolve will have more than €200 million in revenues, more than 1,000 employees and operations across Italy, Germany, Austria, Spain and Portugal. Medisolve is backed by H.I.G. Capital.
Angelo Maresca, CEO of Medisolve, commented: “The acquisition of Mides represents another key milestone in the expansion of our presence in the DACH region and, more broadly, across the European market. Over the years, Mides has built strong and meaningful relationships with its customers, and we are delighted to be able to provide them with continuity while further strengthening and expanding the support available to them. I firmly believe that Medisolve is the ideal partner to support Mides and build on the achievements of its team.”
Dr. Dirk Neukirchen, Managing Partner of Allistro, emphasizes “We are pleased to have found a buyer in the Medisolve Group that will allow MIDES to contribute its expertise within the group and continue to advance technologically. This will strengthen the Graz location and lay the foundation for further growth.”